A role for human leucocyte antigens in the susceptibility to SARS‐Cov‐2 infection observed in transplant patients
International Journal of Immunogenetics · 2020-08 · 47 (4) · 324-328
DOI: 10.1111/iji.12505 ↗Kurz gefasst
Fachartikel in der Zeitschrift International Journal of Immunogenetics, online erschienen am 05.07.2020. Verfasst von Kay Poulton und 10 weiteren Autor:innen. Beteiligte Einrichtung: Transplantation Laboratory, Manchester Royal Infirmary, Manchester, UK. Hauptthemen laut MEDLINE: Histocompatibility Testing. Die Arbeit wurde bisher 44-mal zitiert (Crossref) und nennt 18 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).
Abstract (Originalsprache)
We analysed data from 80 patients who tested positive for SARS‐CoV‐2 RNA who had previously been HLA typed to support transplantation. Data were combined from two adjacent centres in Manchester and Leeds to achieve a sufficient number for early analysis. HLA frequencies observed were compared against two control populations: first, against published frequencies in a UK deceased donor population ( n = 10,000) representing the target population of the virus, and second, using a cohort of individuals from the combined transplant waiting lists of both centres ( n = 308), representing a comparator group of unaffected individuals of the same demographic. We report a significant HLA association with HLA‐ DQB1*06 (53% vs. 36%; p < .012; OR 1.96; 95% CI 1.94–3.22) and infection. A bias towards an increased representation of HLA‐A*26, HLA‐DRB1*15, HLA‐DRB1*10 and DRB1*11 was also noted but these were either only significant using the UK donor controls, or did not remain significant after correction for multiple tests. Likewise, HLA‐A*02, HLA‐B*44 and HLA‐C*05 may exert a protective effect, but these associations did not remain significant after correction for multiple tests. This is relevant information for the clinical management of patients in the setting of the current SARS‐CoV‐2 pandemic and potentially in risk‐assessing staff interactions with infected patients.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Transplantation Laboratory, Manchester Royal Infirmary, Manchester, UK.
- Manchester Academic Health Science Centre, University of Manchester, Manchester, UK.
- Transplant Immunology, St James's University Hospital, Leeds, UK.
- Department Immunology, St James's University Hospital, Leeds, UK.
- Department Renal Medicine, St James's University Hospital, Leeds, UK.
- Department Virology, Manchester Royal Infirmary, Manchester, UK.
ORCID-Profile: Kay Poulton, Paul Wright, Brendan Clark
Zitieren
APA
Poulton, K., Wright, P., Hughes, P., Savic, S., Welberry Smith, M., Guiver, M., Morton, M., van Dellen, D., Tholouli, E., Wynn, R., & Clark, B. (2020). A role for human leucocyte antigens in the susceptibility to SARS‐Cov‐2 infection observed in transplant patients. International Journal of Immunogenetics, 47(4), 324-328. https://doi.org/10.1111/iji.12505
Vancouver
Poulton K, Wright P, Hughes P, Savic S, Welberry Smith M, Guiver M, et al. A role for human leucocyte antigens in the susceptibility to SARS‐Cov‐2 infection observed in transplant patients. International Journal of Immunogenetics. 2020;47(4):324-328. doi:10.1111/iji.12505
BibTeX
@article{Poulton2020,
author = {Poulton, Kay and Wright, Paul and Hughes, Pamela and Savic, Sinisa and Welberry Smith, Matthew and Guiver, Malcolm and Morton, Muir and van Dellen, David and Tholouli, Eleni and Wynn, Robert and Clark, Brendan},
title = {A role for human leucocyte antigens in the susceptibility to SARS‐Cov‐2 infection observed in transplant patients},
journal = {International Journal of Immunogenetics},
year = {2020},
volume = {47},
number = {4},
pages = {324--328},
doi = {10.1111/iji.12505}
}
EUVIMED